Published by Coherent Market Insights
Posted on October 7, 2021
Radiofrequency Ablation is a painless procedure that is done using a narrow needle and a low-level electrical current. The Radiofrequency Ablation procedure is performed by placing a very thin stainless steel needle into each individual follicle. The needle sends out an electrical charge that destroys the follicle so that it will not grow back and cause the surrounding tissue to be inflamed and damaged. It is also less painful and causes less tissue damage. In addition, Radio Frequency Ablation can be performed on almost any area of the skin. This means that it can be used to treat not only acne but also stretch marks, fine lines, and wrinkles, as well as hyperpigmentation and facial spots.
Get a Sample Copy of the Report @
https://www.coherentmarketinsights.com/insight/request-sample/703
In addition to the information presented in this report on the Radio Frequency Ablation Device market, it includes financial losses incurred as a result of COVID-19. It also explains how the most important business sectors in the market are coping with the epidemic and how to get out of it. This market report is a way to present accurate information on company profiles and competitiveness analyses in an orderly manner. It anticipates competition in the market for the planned period from 2021 to 2028. This market study also looks at industry channels and performance rates to help key players stay ahead of the competition.
The growing use of ablation devices for pain management is driving the growth of the global radiofrequency ablation devices market. So, the increasing prevalence of arthritis around the globe is uplifting the growth of the market. According to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, an estimated 54.4 million US adults have been diagnosed with arthritis, which accounted for around 1 in 4 people in the U.S. Moreover, the growing geriatric population is also projected to augment the growth of the radiofrequency ablation devices market. According to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Furthermore, the growing demand for minimally invasive procedures is further projected to foster the growth of the market over the forecast period.
North America is expected to exhibit significant growth over the forecast period and this is attributed to the continuous innovation by ley players in the field of radiofrequency ablation devices. For instance, in November 2020, Abbott announced the launch of the IonicRF
Generator – a new device recently cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
Key Developments:
In May 2019, Boston Scientific Corporation entered into a definitive agreement to acquire Vertiflex, Inc., a developer of minimally-invasive devices for pain management.
In February 2019, Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio frequency (RF) ablation of nerve tissues.
Ask for PDF sample copy of this report @
https://www.coherentmarketinsights.com/insight/request-pdf/703
The major players covered in Radio Frequency Ablation Device Market:
Boston Scientific, St Jude Medical, Medtronic, Covidien and Stryker. Other prominent vendors include Imricor Medical Systems, AtriCure, BIOTRONIK, MicroPort Scientific and Spacelabs Healthcare.
Reasons to purchase this research report:
• Extensive analysis on key trends and opportunities on the industries ongoing trends in different regions across the globe
• All-inclusive assessment on recent technological advancements and forecast of the upcoming decade
• A comparative analysis of leading players and emerging players in the market
• Reliable information on new product launches, organic and inorganic strategies, and more
• Valuable insights on the impact of regulatory framework on the market
Buy This Complete A Business Report With Flat $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/703
Key Questions Answered in the report include
What benefits does the CMI research study is going to provide?
• Latest industry influencing trends and development scenario
• To Seize powerful market opportunities
• Key decision in planning and to further expand market share
• Identify Key Business Segments, Market proposition & Gap Analysis
• Assisting in allocating marketing investments
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Radio Frequency Ablation Device Market 2021 Business Demand, Future Scope, 2028 | Boston Scientific, St Jude Medical, Medtronic, Covidien and Stryker appeared first on Gatorledger.
Radiofrequency Ablation is a painless procedure that is done using a narrow needle and a low-level electrical current. The Radiofrequency Ablation procedure is performed by placing a very thin stainless steel needle into each individual follicle. The needle sends out an electrical charge that destroys the follicle so that it will not grow back and cause the surrounding tissue to be inflamed and damaged. It is also less painful and causes less tissue damage. In addition, Radio Frequency Ablation can be performed on almost any area of the skin. This means that it can be used to treat not only acne but also stretch marks, fine lines, and wrinkles, as well as hyperpigmentation and facial spots.
Get a Sample Copy of the Report @
https://www.coherentmarketinsights.com/insight/request-sample/703
In addition to the information presented in this report on the Radio Frequency Ablation Device market, it includes financial losses incurred as a result of COVID-19. It also explains how the most important business sectors in the market are coping with the epidemic and how to get out of it. This market report is a way to present accurate information on company profiles and competitiveness analyses in an orderly manner. It anticipates competition in the market for the planned period from 2021 to 2028. This market study also looks at industry channels and performance rates to help key players stay ahead of the competition.
The growing use of ablation devices for pain management is driving the growth of the global radiofrequency ablation devices market. So, the increasing prevalence of arthritis around the globe is uplifting the growth of the market. According to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, an estimated 54.4 million US adults have been diagnosed with arthritis, which accounted for around 1 in 4 people in the U.S. Moreover, the growing geriatric population is also projected to augment the growth of the radiofrequency ablation devices market. According to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Furthermore, the growing demand for minimally invasive procedures is further projected to foster the growth of the market over the forecast period.
North America is expected to exhibit significant growth over the forecast period and this is attributed to the continuous innovation by ley players in the field of radiofrequency ablation devices. For instance, in November 2020, Abbott announced the launch of the IonicRF Generator – a new device recently cleared by the U.S. Food and Drug Administration to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
Key Developments:
In May 2019, Boston Scientific Corporation entered into a definitive agreement to acquire Vertiflex, Inc., a developer of minimally-invasive devices for pain management.
In February 2019, Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio frequency (RF) ablation of nerve tissues.
Ask for PDF sample copy of this report @
https://www.coherentmarketinsights.com/insight/request-pdf/703
The major players covered in Radio Frequency Ablation Device Market:
Boston Scientific, St Jude Medical, Medtronic, Covidien and Stryker. Other prominent vendors include Imricor Medical Systems, AtriCure, BIOTRONIK, MicroPort Scientific and Spacelabs Healthcare.
Reasons to purchase this research report:
• Extensive analysis on key trends and opportunities on the industries ongoing trends in different regions across the globe
• All-inclusive assessment on recent technological advancements and forecast of the upcoming decade
• A comparative analysis of leading players and emerging players in the market
• Reliable information on new product launches, organic and inorganic strategies, and more
• Valuable insights on the impact of regulatory framework on the market
Buy This Complete A Business Report With Flat $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/703
Key Questions Answered in the report include
What benefits does the CMI research study is going to provide?
• Latest industry influencing trends and development scenario
• To Seize powerful market opportunities
• Key decision in planning and to further expand market share
• Identify Key Business Segments, Market proposition & Gap Analysis
• Assisting in allocating marketing investments
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Radio Frequency Ablation Device Market 2021 Business Demand, Future Scope, 2028 | Boston Scientific, St Jude Medical, Medtronic, Covidien and Stryker appeared first on Gatorledger.
Explore more articles in the Research Reports category
